Back to Search
Start Over
Clinical effects of SGLT2 inhibitors in seven persons with HNF1A‐MODY (MODY3).
- Source :
- Diabetic Medicine; Oct2024, Vol. 41 Issue 10, p1-4, 4p
- Publication Year :
- 2024
-
Abstract
- The article focuses on the use of SGLT2 inhibitors in patients with HNF1A-MODY, a type of monogenic diabetes. Topics include the typical treatment regimen for HNF1A-MODY, the observed clinical outcomes from adding SGLT2 inhibitors to existing therapies, and the specific HNF1A genetic variants found in the study participants.
Details
- Language :
- English
- ISSN :
- 07423071
- Volume :
- 41
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Diabetic Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 180376174
- Full Text :
- https://doi.org/10.1111/dme.15387